Improved protofibril selective antibodies and the use thereof

Details for Australian Patent Application No. 2007227813 (hide)

Owner Bioarctic Neuroscience AB

Inventors Gellerfors, Par; Ekholm Pettersson, Frida; Englund, Hillevi; Sehlin, Dag; Lannfelt, Lars

Agent Davies Collison Cave

Pub. Number AU-B-2007227813

PCT Pub. Number WO2007/108756

Priority 0602591-0 30.11.06 SE; 0600662-1 23.03.06 SE

Filing date 23 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 27 September 2012

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 Drugs for disorders of the nervous system

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/108756 Priority application(s): WO2007/108756

27 September 2012 Application Accepted

  Published as AU-B-2007227813

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227818-Cooling arrangement in a vehicle

2007227811-Crystalline forms of N- {2-tert -butyl -1- [ (4,4dif luorocyclohexyl) methyl] - lH-benzimidazol-5yl}ethanesulfonamide salts